Long-term outcomes of ultrasound guided high intensity focused ultrasound ablation for patients with uterine fibroids classified by T2WI: a multicenter retrospective study

References

• Chen J, Li Y, Wang Z, et al. Evaluation of high-intensity focused ultrasound ablation for uterine fibroids: an IDEAL prospective exploration study. BJOG. 2018;125(3):354–364.
   PubMed Web of Science ®Google Scholar
• Liu X, Tang J, Luo Y, et al. Comparison of high-intensity focused ultrasound ablation and secondary myomectomy for recurrent symptomatic uterine fibroids following myomectomy: a retrospective study. BJOG. 2020;127(11):1422–1428.
   PubMed Web of Science ®Google Scholar
• Peng S, Zhang L, Hu L, et al. Factors influencing the dosimetry for high-intensity focused ultrasound ablation of uterine fibroids: a retrospective study. Medicine. 2015;94(13):e650.
   PubMed Web of Science ®Google Scholar
• Funaki K, Sawada K, Maeda F, et al. Subjective effect of magnetic resonance-guided focused ultrasound surgery for uterine fibroids. J Obstet Gynaecol Res. 2007;33(6):834–839.
   PubMed Web of Science ®Google Scholar
• Zhao WP, Chen JY, Zhang L, et al. Feasibility of ultrasound-guided high intensity focused ultrasound ablating uterine fibroids with hyperintense on T2-weighted MR imaging. Eur J Radiol. 2013;82(1):e43–e49.
   PubMed Web of Science ®Google Scholar
• Zhao WP, Zhang J, Han ZY, et al. A clinical investigation treating different types of fibroids identified by MRI-T2WI imaging with ultrasound guided high intensity focused ultrasound. Sci Rep. 2017;7(1):10812.
   PubMed Web of Science ®Google Scholar
• Funaki K, Fukunishi H, Sawada K. Clinical outcomes of magnetic resonance-guided focused ultrasound surgery for uterine myomas: 24-month follow-up. Ultrasound Obstet Gynecol. 2009;34(5):584–589.
   PubMed Web of Science ®Google Scholar
• Yang MJ, Yu RQ, Chen WZ, et al. A prediction of NPVR ≥ 80% of ultrasound-guided high-intensity focused ultrasound ablation for uterine fibroids. Front Surg. 2021;8:663128.
   PubMed Web of Science ®Google Scholar
• Huang H, Ran J, Xiao Z, et al. Reasons for different therapeutic effects of high-intensity focused ultrasound ablation on excised uterine fibroids with different signal intensities on T2-weighted MRI: a study of histopathological characteristics. Int J Hyperthermia. 2019;36(1):477–484.
   PubMed Web of Science ®Google Scholar
• Zhao WP, Chen JY, Chen WZ. Effect of biological characteristics of different types of uterine fibroids, as assessed with T2-weighted magnetic resonance imaging, on ultrasound-guided high-intensity focused ultrasound ablation. Ultrasound Med Biol. 2015;41(2):423–431.
   PubMed Web of Science ®Google Scholar
• Gorny KR, Woodrum DA, Brown DL, et al. Magnetic resonance-guided focused ultrasound of uterine leiomyomas: review of a 12-month outcome of 130 clinical patients. J Vasc Intervent Radiol. 2011;22(6):857–864.
   PubMed Web of Science ®Google Scholar
• Zhao WP, Chen JY, Chen WZ. Dynamic contrast-enhanced MRI serves as a predictor of HIFU treatment outcome for uterine fibroids with hyperintensity in T2-weighted images. Exp Ther Med. 2016;11(1):328–334.
   PubMed Web of Science ®Google Scholar
• Li W, Jiang Z, Deng X, et al. Long-term follow-up outcome and reintervention analysis of ultrasound-guided high intensity focused ultrasound treatment for uterine fibroids. Int J Hyperthermia. 2020;37(1):1046–1051.
   PubMed Web of Science ®Google Scholar
• Xu F, Deng L, Zhang L, et al. The comparison of myomectomy, UAE and MRgFUS in the treatment of uterine fibroids: a meta analysis. Int J Hyperthermia. 2021;38(2):24–29.
   PubMed Web of Science ®Google Scholar
• Park MJ, Kim YS, Rhim H, et al. Safety and therapeutic efficacy of complete or near-complete ablation of symptomatic uterine fibroid tumors by MR imaging-guided high-intensity focused US therapy. J Vasc Interv Radiol. 2014;25(2):231–239.
   PubMed Web of Science ®Google Scholar
• Keserci B, Duc NM, Nadarajan C, et al. Volumetric MRI-guided, high-intensity focused ultrasound ablation of uterine leiomyomas: ASEAN preliminary experience. Diagn Interv Radiol. 2020;26(3):207–215.
   PubMed Web of Science ®Google Scholar
• Yamashita Y, Torashima M, Takahashi M, et al. Hyperintense uterine leiomyoma at T2-weighted MR imaging: differentiation with dynamic enhanced MR imaging and clinical implications. Radiology. 1993;189(3):721–725.
   PubMed Web of Science ®Google Scholar
• Funaki K, Fukunishi H, Funaki T, et al. Magnetic resonance-guided focused ultrasound surgery for uterine fibroids: relationship between the therapeutic effects and signal intensity of preexisting T2-weighted magnetic resonance images. Am J Obstet Gynecol. 2007;196(2):184.e1–184.e6.
   PubMedGoogle Scholar
• Lenard ZM, McDannold NJ, Fennessy FM, et al. Uterine leiomyomas: MR imaging-guided focused ultrasound surgery—imaging predictors of success. Radiology. 2008;249(1):187–194.
   PubMed Web of Science ®Google Scholar
• Bonine NG, Banks E, Harrington A, et al. Contemporary treatment utilization among women diagnosed with symptomatic uterine fibroids in the United States. BMC Womens Health. 2020;20(1):174.
   PubMed Web of Science ®Google Scholar
• Davis MR, Soliman AM, Castelli-Haley J, et al. Reintervention rates after myomectomy, endometrial ablation, and uterine artery embolization for patients with uterine fibroids. J Womens Health. 2018;27(10):1204–1214. Oct
   PubMed Web of Science ®Google Scholar
• Daniels J, Middleton LJ, Cheed V, et al. Uterine artery embolization or myomectomy for women with uterine fibroids: four-year follow-up of a randomised controlled trial. Eur J Obstet Gynecol Reprod Biol X. 2022;13:100139.
   PubMedGoogle Scholar
• Lozinski T, Filipowska J, Krol P, et al. Oxytocin administration in High-Intensity focused ultrasound treatment of myomata. Biomed Res Int. 2018;2018:7518026.
   PubMed Web of Science ®Google Scholar
• Otonkoski S, Sainio T, Komar G, et al. Oxytocin selectively reduces blood flow in uterine fibroids without an effect on myometrial blood flow: a dynamic contrast enhanced MRI evaluation. Int J Hyperthermia. 2020;37(1):1293–1300.
   PubMed Web of Science ®Google Scholar
• Jiang L, Yu JW, Yang MJ, et al. Ultrasound-guided HIFU for uterine fibroids of hyperintense on T2-weighted MR imaging with or without GnRH-analogue-pretreated: a propensity score matched cohort study. Front Surg. 2022;9:975839.
   PubMed Web of Science ®Google Scholar
• Gorny KR, Borah BJ, Brown DL, et al. Incidence of additional treatments in women treated with MR-guided focused US for symptomatic uterine fibroids: review of 138 patients with an average follow-up of 2.8 years. J Vasc Interv Radiol. 2014;25(10):1506–1512.
   PubMed Web of Science ®Google Scholar